P-80 Analysis of plasma angiogenesis factors on the efficacy of FOLFIRI plus ramucirumab and FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer from WJOG9216G randomized phase II study
Titel:
P-80 Analysis of plasma angiogenesis factors on the efficacy of FOLFIRI plus ramucirumab and FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer from WJOG9216G randomized phase II study
Auteur:
Yamada, T. Kito, Y. Sakai, K. Nishio, K. Yamazaki, K. Shoji, H. Tsushima, T. Mitani, S. Shiraishi, K. Yasui, H. Hara, H. Shimozaki, K. Esaki, T. Shimokawa, H. Tsuzuki, T. Kajiura, S. Masuishi, T. Baba, E. Yoshimura, K. Kawakami, H. Hironaka, S. Muro, K.